Investor relations

Listed on NASDAQ since 1991 and a member of the S&P 500®, IDEXX Laboratories, Inc. (IDXX) is the global leader in veterinary diagnostics, software, and water microbiology testing.

Listen: Q3 2022 earnings call

IDXX $411.36*
-5.17 (-1.24%)

Q3 2022 Results - November 1

Corporate Responsibility Report

Corporate Responsibility is fundamental to how IDEXX operates as a business, employer, supplier, customer, and member of the community.

Read our 2021 report

Investor resources

Upcoming earnings dates

Q4 2022: February 6

Investor resources

Investor Relations
One IDEXX Drive
Westbrook, Maine 04092

1-207-556-8155 or 1-800-548-6733
Fax: 1-207-556-4427
Email

Latest news

IDEXX Laboratories Announces Third Quarter Results

IDEXX Announces Second Quarter Results

IDEXX Announces New Goals in Its 2021 Corporate Responsibility Report and Advances Progress on Environmental, Social, and Governance Initiatives
Read more

IDEXX Empowers Veterinarians with New Testing Insights that Support Earlier Diagnosis and Intervention for Preventive Care and Critical Cases
Read more

IDEXX to Present at Stifel Conference and IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
Read more

IDEXX Announces First Quarter Results

IDEXX to Present at Two Upcoming Institutional Investor Conferences
Read more

IDEXX Announces Fourth Quarter and Full Year 2021 Results

IDEXX Innovative Diagnostic and Software Solutions Provide Workflow Efficiency and Faster, More Confident Clinical Decisions
Read more

IDEXX Enables Improved Cancer Diagnosis and Personalized Care through Expanded Oncology Offering
Read more

IDEXX Acquires ezyVet
Read more

IDEXX and the Tuskegee University College of Veterinary Medicine Announce Landmark Initiative
Read more

IDEXX Elects Dr. Asha S. Collins to Board of Directors
Read more

IDEXX Provides U.S. Companion Animal Market Trends Update
Read more

View the U.S. Companion Animal Market Trends Snapshot

IDEXX Launches Groundbreaking New ProCyte One Hematology Analyzer with Dramatically Simplified User Experience
Read more

IDEXX Expands ImageVue Digital Imaging Portfolio, Making Enhanced Radiation Safety and Superior Diagnostic Image Quality Affordable to More Veterinarians
Read more

OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
Read more

IDEXX Provides U.S. Companion Animal Market Trends Update
Read more

View the U.S. Companion Animal Market Trends Snapshot

OPTI Medical Systems Receives US FDA Emergency Use Authorization for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
Read more

IDEXX Makes Pet Test for COVID-19 Virus Available to Veterinarians
Read more

IDEXX Newsroom

Events and presentations

IDEXX Third Quarter 2022 Earning Conference Call
November 1, 2022, 8:30 am EDT

IDEXX Investor Day (webcast replay)
Thursday, August 11, 2022
View presentation

IDEXX Second Quarter 2022 Earnings Conference Call
August 2, 2022, 8:30 am EDT

Stifel Jaws & Paws Conference
Wednesday, June 1, 2022, 1:50-2:20 pm EDT

IDEXX 2022 Annual Meeting of Shareholders:  Answers to Shareholders’ Questions
View document

IDEXX First Quarter 2022 Earnings Conference Call
Wednesday, May 4, 2022, 8:30 am EDT

43rd Annual Raymond James Institutional Investors Conference
Monday, March 7, 2022, 11:00 am EST
View presentation

IDEXX Fourth Quarter 2021 Earnings Conference Call
Wednesday, February 2, 2022, 8:30 am EST

IDEXX Third Quarter 2021 Earnings Conference Call
Tuesday, November 2, 2021, 8:30 am EDT

IDEXX Virtual Investor Day
Thursday, August 12, 2021, 10:00 am EDT
View presentation

IDEXX Second Quarter 2021 Earnings Conference Call
Friday, July 30, 2021, 8:30 am EDT

View all events and presentations

*Pricing delayed by 20 minutes